Cell dissociation is the process of separating cells from tissues or sets in single-cell suspension using enzymatic, chemical or mechanical methods. This is an important step in cell culture, regenerative medicine, single-cell analysis and biopharmaceutical production. Cell separation market growth is inspired by increasing demand for cell-based research, expanding applications in cancer and stem cell therapy, increasing investment in biopharma and biotechnology and progress in single-cell technologies. Additionally, increasing attention to individual medical and high- throughput drug screening and enhances the market demand for efficient and soft separation solutions.
Key Growth Drivers and Opportunities
Increasing Demand for Cell-Based Research: The increasing demand for cell-based research significantly increases the development of the cell separation market, as separating viable single cells is a fundamental requirement for various cellular studies. Search-based research drug discovery, cancer biology, stem cell therapy and regenerative therapy underline, which rely on the high-quality cell suspension obtained through effective separation methods. As researchers aim to understand cellular behavior at single-cell level, gene expression and disease system, the need for accurate, gentle and scalable cell separation technologies increases. This increasing demand promotes innovation and investment in advanced separation devices, increasing the overall market growth.
Challenges
The cell separation market faces several borders, including challenges in maintaining cell feasibility, functionality and integrity during the separation process. Hard enzymatic or mechanical methods can damage sensitive cells, especially stem cells or primary cells, which affect downstream applications. Additionally, lack of standardized protocols in different tissue types can lead to inconsistent consequences and can reduce copy. Along with the requirement of skilled personnel, high cost of advanced separation reagents and equipment limits, especially small research laboratories and emerging markets limit the extent of adopting.
Innovation and Expansion
The sCelLiVE Kit from Singleron Makes Skin Tissue Dissociation Easier
In September 2024, A novel all-in-one solution for human and mouse skin tissue, the sCelLiVE Tissue Dissociation Kit (Skin) (sCelLiVE Skin), was introduced by Singleron. High-quality downstream analysis, including single cell sequencing, is made possible by the novel product’s considerable processing time reduction while maintaining cell viability and characteristics.
The skin is a complicated tissue that takes a long time to separate. In order to overcome these difficulties, sCelLiVE Skin uses an automated process that dissociates the entire skin without requiring the layers of dermis and epidermis to be separated. It cuts the overall processing time down to 60–120 minutes from the existing 3 hours to 2 days.
VitroGel Organoid Recovery Solution for High-Yield Cell Harvesting Introduced by TheWell Bioscience
In February 2023, A newly developed cell harvesting solution is released by TheWell Bioscience, a leader in 3D cell culture platforms for precision medicine, cell therapy, and biomanufacturing, to recover organoids and cells more quickly and efficiently. The first of its kind, the VitroGel Organoid Recovery Solution is capable of recovering organoids from synthetic VitroGel hydrogels as well as extracellular matrix (ECM) derived from animals.
Higher yields, quality, and cell survival for organoid growth are the outcomes of the quick 2-minute total dissociation of animal-based extracellular matrix. Complete lab automation for high-throughput organoid synthesis is made possible by the operational procedure being carried out at room temperature without the use of heat or cooling equipment.
Inventive Sparks, Expanding Markets
The key players operating the cell dissociation market includes, Thermo Fisher Scientific, Becton, Roche Diagnostics, Danaher Corporation, STEMCELL Technologies, Miltenyi Biotec, VitaCyte, LLC, PAN-Biotech, Merck KGaA, HiMedia Laboratories.
About Author:
Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.
